Kenny Simmen,

Vice President, Scientific Innovation, Infectious Diseases and Vaccines

Kenny is Vice President of Scientific Innovation, Infectious Diseases and Vaccines at Johnson & Johnson Innovation. Kenny has global responsibility for sourcing pipeline opportunities and collaborations for the Janssen Infectious Diseases & Vaccines team in the Innovation Centers.

Kenny joined the Johnson & Johnson Family of Companies in 1997, initially in the Pharmaceutical Research & Development group in La Jolla, California, and then moving to Belgium to join the newly-acquired Tibotec in 2002 to lead HCV research.

Kenny holds an BSc (Hons) degree in Molecular Biology from the University of Edinburgh, Scotland, and obtained his PhD at the European Molecular Biology Laboratory (EMBL), Heidelberg.  He trained as a postdoc (EMBO and HFSP Fellowships) with Prof Bernards at the Netherlands Cancer Institute in Amsterdam on viral transcription factors, before entering the pharmaceutical industry with Roche UK, where he worked on antiviral drug discovery against herpes viruses. 

Kenny Simmen
Kenny Simmen